Showing results (71-80 of 177) with videos related to
Sort By:
Pageof 18
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 4, 2019
Incidence, Predictors, and Outcomes of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Reduced-Intensity Allogeneic Hematopoietic Cell TransplantationClinton Lewis, Haesook T Kim, Lindsey E Roeker, et al.Blood Advances|January 4, 2018
Vaccination with autologous myeloblasts admixed with GM-K562 cells in patients with advanced MDS or AML after allogeneic HSCTVincent T Ho, Haesook T Kim, Natalie Bavli, et al.American Journal of Hematology|June 13, 2025
Poor Engraftment After Posttransplant Cyclophosphamide Graft-Versus-Host DISAESE Prophylaxis in Patients With MyelofibrosisHaesook T Kim, Deborah J Liney, Kristen Rizza, et al.Proceedings of the National Academy of Sciences of the United States of America|September 1, 2009
Biologic activity of irradiated, autologous, GM-CSF-secreting leukemia cell vaccines early after allogeneic stem cell transplantationVincent T Ho, Matthew Vanneman, Haesook Kim, et al.Leukemia|November 18, 2020
Fit older adults with advanced myelodysplastic syndromes: who is most likely to benefit from transplant?Gregory A Abel, Haesook T Kim, Andrew Hantel, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 22, 2011
Reduced-intensity conditioning stem cell transplantation: comparison of double umbilical cord blood and unrelated donor graftsYi-Bin Chen, Julie Aldridge, Haesook T Kim, et al.Blood Advances|February 9, 2021
COVID-19 and hematopoietic stem cell transplantation and immune effector cell therapy: a US cancer center experienceKatie Maurer, Anna Saucier, Haesook T Kim, et al.Blood Advances|August 21, 2023
Real-world experience with low-dose IL-2 for children and young adults with refractory chronic graft-versus-host diseaseHolly Wobma, Malika Kapadia, Haesook T Kim, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 25, 2014
Angiogenic cytokines are antibody targets during graft-versus-leukemia reactionsMatthias Piesche, Vincent T Ho, Haesook Kim, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 22, 2010
Iron overload in patients with acute leukemia or MDS undergoing myeloablative stem cell transplantationPhilippe Armand, Haesook T Kim, Joanna Rhodes, et al.Pageof 18